These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 30509087)
21. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma. Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143 [TBL] [Abstract][Full Text] [Related]
22. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies. Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101 [TBL] [Abstract][Full Text] [Related]
23. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Krauthammer M; Kong Y; Ha BH; Evans P; Bacchiocchi A; McCusker JP; Cheng E; Davis MJ; Goh G; Choi M; Ariyan S; Narayan D; Dutton-Regester K; Capatana A; Holman EC; Bosenberg M; Sznol M; Kluger HM; Brash DE; Stern DF; Materin MA; Lo RS; Mane S; Ma S; Kidd KK; Hayward NK; Lifton RP; Schlessinger J; Boggon TJ; Halaban R Nat Genet; 2012 Sep; 44(9):1006-14. PubMed ID: 22842228 [TBL] [Abstract][Full Text] [Related]
24. Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and Pyrosequencing. McEvoy AC; Wood BA; Ardakani NM; Pereira MR; Pearce R; Cowell L; Robinson C; Grieu-Iacopetta F; Spicer AJ; Amanuel B; Ziman M; Gray ES J Mol Diagn; 2018 Mar; 20(2):240-252. PubMed ID: 29305225 [TBL] [Abstract][Full Text] [Related]
25. Somatic driver mutations in melanoma. Reddy BY; Miller DM; Tsao H Cancer; 2017 Jun; 123(S11):2104-2117. PubMed ID: 28543693 [TBL] [Abstract][Full Text] [Related]
26. Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma. Halait H; Demartin K; Shah S; Soviero S; Langland R; Cheng S; Hillman G; Wu L; Lawrence HJ Diagn Mol Pathol; 2012 Mar; 21(1):1-8. PubMed ID: 22306669 [TBL] [Abstract][Full Text] [Related]
27. Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues. Schiefer AI; Parlow L; Gabler L; Mesteri I; Koperek O; von Deimling A; Streubel B; Preusser M; Lehmann A; Kellner U; Pauwels P; Lambin S; Dietel M; Hummel M; Klauschen F; Birner P; Möbs M J Mol Diagn; 2016 May; 18(3):370-377. PubMed ID: 26921540 [TBL] [Abstract][Full Text] [Related]
28. Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma. Franczak C; Salleron J; Dubois C; Filhine-Trésarrieu P; Leroux A; Merlin JL; Harlé A Mol Diagn Ther; 2017 Apr; 21(2):209-216. PubMed ID: 28130756 [TBL] [Abstract][Full Text] [Related]
29. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases. Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561 [TBL] [Abstract][Full Text] [Related]
30. Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing. Colomba E; Hélias-Rodzewicz Z; Von Deimling A; Marin C; Terrones N; Pechaud D; Surel S; Côté JF; Peschaud F; Capper D; Blons H; Zimmermann U; Clerici T; Saiag P; Emile JF J Mol Diagn; 2013 Jan; 15(1):94-100. PubMed ID: 23159108 [TBL] [Abstract][Full Text] [Related]
31. Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas. Kakavand H; Crainic O; Lum T; O'Toole SA; Kefford RF; Thompson JF; Wilmott JS; Long GV; Scolyer RA Pathology; 2014 Apr; 46(3):193-8. PubMed ID: 24614711 [TBL] [Abstract][Full Text] [Related]
32. Somatic mutation analysis in melanoma using targeted next generation sequencing. Miraflor AP; de Abreu FB; Peterson JD; Turner SA; Amos CI; Tsongalis GJ; Yan S Exp Mol Pathol; 2017 Oct; 103(2):172-177. PubMed ID: 28822769 [TBL] [Abstract][Full Text] [Related]
33. Lymph node metastases of melanoma: challenges for BRAF mutation detection. Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393 [TBL] [Abstract][Full Text] [Related]
34. Comparison between two widely used laboratory methods in BRAF V600 mutation detection in a large cohort of clinical samples of cutaneous melanoma metastases to the lymph nodes. Jurkowska M; Gos A; Ptaszyński K; Michej W; Tysarowski A; Zub R; Siedlecki JA; Rutkowski P Int J Clin Exp Pathol; 2015; 8(7):8487-93. PubMed ID: 26339422 [TBL] [Abstract][Full Text] [Related]
35. BRAFV600E detection in melanoma is highly improved by COLD-PCR. Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C Clin Chim Acta; 2011 May; 412(11-12):901-5. PubMed ID: 21262211 [TBL] [Abstract][Full Text] [Related]
36. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues. Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585 [TBL] [Abstract][Full Text] [Related]
37. Detection of Rare Mutations by Routine Analysis of KRAS, NRAS, and BRAF Oncogenes. Mikhailenko DS; Efremov GD; Safronova NY; Strelnikov VV; Alekseev BY Bull Exp Biol Med; 2017 Jan; 162(3):375-378. PubMed ID: 28091917 [TBL] [Abstract][Full Text] [Related]
38. Machine learning algorithm improved automated droplet classification of ddPCR for detection of BRAF V600E in paraffin-embedded samples. Colozza-Gama GA; Callegari F; Bešič N; Paniza ACJ; Cerutti JM Sci Rep; 2021 Jun; 11(1):12648. PubMed ID: 34135377 [TBL] [Abstract][Full Text] [Related]
39. Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays. Qu K; Pan Q; Zhang X; Rodriguez L; Zhang K; Li H; Ho A; Sanders H; Sferruzza A; Cheng SM; Nguyen D; Jones D; Waldman F J Mol Diagn; 2013 Nov; 15(6):790-5. PubMed ID: 23994118 [TBL] [Abstract][Full Text] [Related]
40. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction. Turner DJ; Zirvi MA; Barany F; Elenitsas R; Seykora J J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]